Labcorp (LH) has been benefiting from the solid execution of its strategic priorities. Investment in targeted high-growth areas should continue to drive the momentum. The company faces headwinds from macroeconomic uncertainties and currency translations. The stock carries a Zacks Rank #3 (Hold) currently. As part of its expansion efforts, Labcorp is focusing more on key growth areas such as oncology, women's health, autoimmune disease and neurology. The company's ability to develop, license and ultimately s ...